News Releases

A team led by Penn Medicine and the University of California San Diego has been awarded a $6.9 million grant from the National Institute on Aging to prepare a potential disease-modifying Alzheimer’s treatment for future clinical trials.

A team of researchers led by Penn Medicine will investigate the link between traumatic brain injuries and Alzheimer’s disease and related dementias with a $10 million grant from the National Institute of Neurological Disorders and Stroke.

The rate of stroke, in individuals with no history of prior stroke, was 34 percent higher in individuals who experienced at least one head injury than in their peers with no head injury.

The structural differences in male and female brains might explain why females are more prone to concussions and experience longer recovery from the injury than their male counterparts, according to Penn Medicine research.

A drug initially developed as an immunosuppressant for organ transplant patients slowed the cognitive effects of Alzheimer’s disease in mouse models.

Researchers from the Perelman School of Medicine will present data on the latest research across the full spectrum of Neurology at the American Academy of Neurology Annual Meeting.

Only a very small percentage of neurons show changes after an epileptic seizure in mice, but these alterations can be permanent and trigger future seizures. An experimental treatment may prevent these long-term changes.

By generally improving neuronal and cellular health, experts can mitigate or delay disease progression

Building upon the expertise in dementia research and care across Penn Medicine, the health system has been awarded a $5 million grant to support the IOA’s work to develop the next generation of therapies for Alzheimer’s disease and related dementias.